Ricardo Carvalho
@rcarvalhoonco
Followers
2K
Following
34K
Statuses
16K
Medical Oncologist at BP Mirante Hospital. Former fellow at @HCBarretos. Focus in GI & GU Cancer. #PancSM #CRCSM #KCSM #GiCSM #GC #PCSM. Tweets are my own
Sao Paulo, Brazil
Joined September 2010
RT @APCCC_Lugano: Friends at #GU25 Presenting our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LI…
0
15
0
RT @ArndtVogel: Liver metastases do not predict resistance to the addition of atezolizumab to FOLFOXIRI + bevacizumab in proficient MMR mCR…
0
7
0
RT @neerajaiims: Ab#66 @ASCO #GU25 by @DrRanaMcKay👉�Triplet Rx w/ darolutamide vs abiraterone in real-world in mHSPC…
0
20
0
RT @dr_yakupergun: ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric ju…
0
25
0
RT @yekeduz_emre: 🏃🏻 Just warming up for @ASCO #GU25! ✨🔥 📌Here my Top10 selection during the meeting! For more and enjoy, please join us i…
0
31
0
RT @NiuSanford: Ph I trial of pre-op SBRT for resectable pancreas ca: R0 resection rate 100%. Vs NORPACT1 neoadjuvant chemo arm alone R0 5…
0
32
0
RT @Gio_Marchegiani: Prognostic factors 🔮 in resected pancreatic cancer: personalized model according to neoadjuvant chemo 🇺🇸🇳🇱 2.7k PDAC…
0
13
0
Great opportunity to improve your knowledge about GI cancers! Definitely a must see in your agenda!
Join us April 4-5 in Santa Barbara (or via livestream) for Gastrointestinal Cancers 2025! Speaker experts will cover the latest updates in treatment of the whole spectrum of GI cancers. Program schedule & registration: #pancreascancer #colorectalcancer #cholangiocarcinoma #gastricancer #livercancer #GIcancer @MayoCancerCare
0
1
5
RT @DraMartinezLago: Updated treatment recommendations for third and further lines of treatment in advanced colorectal cancer: from the ESM…
0
47
0
RT @AnnSurgOncol: #AudioVisualAbstract : #NeuroendocrineTumors of Unknown Primary in the Setting of Cytoreductive #Hepatectomy @HallberaG @…
0
7
0
RT @Dr_ElvinaA: New findings from the phase III FIRE-4 trial, published in @JCO_ASCO , confirm that liquid biopsy accurately identifies R…
0
11
0
RT @ShaalanBeg: #gi25 Update on this: Breakwater trial shows significant survival advantage to targeted therapy for BRAF mutated colorecta…
0
5
0
RT @ArndtVogel: Trial of Gemcitabine, Cisplatin & Nab-Paclitaxel vs Gemcitabine/ Cisplatin in BTC @JCO_ASCO 🔎SWOG…
0
24
0
RT @ArndtVogel: Combined Analyses of ctDNA &Immunoscore in Stage III Colon Cancer 🔎Post Hoc of te PRODIGE-GERCOR IDEA-France/ HORG-IDEA-Gre…
0
13
0
RT @tuttsakhil: Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the Inter…
0
4
0
RT @ArndtVogel: 🔥off the press Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival…
0
3
0
RT @ArndtVogel: Thermal ablation versus surgical resection of small-size colorectal liver metastases @TheLancetOncol
0
18
0
RT @CheatUrology: 🧵📢 #EAUguidelines on muscle-invasive and metastatic bladder cancer (MIBC): Updates on adjuvant therapy and metastatic dis…
0
48
0